Curated coverage for heart disease with top developments, timeline context, and connected threads.
Getting patients to take daily cholesterol-lowering drugs is one of medicine's biggest challenges. Gene editing could solve it with a single treatment. Here is the science, the trials, and what comes next.
Bulk Importer | Linked source
GLP-1 drugs like Ozempic won FDA approvals for addiction, kidney disease, and heart failure in 2026. Here is the full science behind what these drugs are actually doing to the human body.
EuroBulletin24 Editorial Desk | Linked source